April 22 - 26, 2024
Seattle, Washington
May 7 - 9, 2024 (Virtual)
Symposium Supporters
2024 MRS Spring Meeting & Exhibit
SB01.02.02

Core-Shell Semiconducting Polymer Nanoparticles for Detection and Photothermal Ablation of Breast Cancer

When and Where

Apr 23, 2024
2:00pm - 2:15pm
Room 428, Level 4, Summit

Presenter(s)

Co-Author(s)

Nicole Levi1,Santu Sarkar1

Wake Forest University School of Medicine1

Abstract

Nicole Levi1,Santu Sarkar1

Wake Forest University School of Medicine1
Triple negative breast cancer (TNBC) is one of the deadliest among other subtypes of breast cancers due to its absence of standard biomarker expressions, and the aggressive nature of TNBC leads to low patient survival. Current treatment strategies include surgery, chemotherapy, and radiation therapy, although photothermal therapy is an evolving treatment strategy. It has recently been shown that breast cancer can harbor intracellular bacteria, which may impact therapeutic responses. Here we present the use of semiconducting theranostic polymer nanoparticles composed of a photothermal poly[4,4-bis(2-ethylhexyl)- cyclopenta[2,1-b;3,4-b′]-dithiophene-2,6-diyl-alt-2,1,3-benzoselenadiazole-4,7-diyl] (PCPDTBSe) core with a fluorescent poly[(9,9-dihexylfluorene)-co-2,1,3-benzothiadiazole-co-4,7-di(thiophen-2-yl)-2,1,3-benzothiadiazole (PFBTDBT10) shell for detection and treatment of TNBC cells harboring Staphylococcus aureus bacteria. These dual polymer core-shell nanoparticles (CSNPs) had absorption maxima at 450 nm and 740 nm corresponding to PCPDTBSe and DBT10 respectively. The quantum yield was 9.64% The core diameter was 83 nm and the CSNPs were 125 nm, both with negative zeta potential. Exposure of TNBC cells (MDA MB 231) to the CSNPs for 24 h resuslted in a 50% reduction in viability, wheras non-tumorigenic breast epitherlial cells (MCF 10A) were not impacted at 250 ug/ml in the absence of infrared light. Exposure to 800 nm resulted in a temperature change of 15°C at 250 ug/ml of CSNPs exposed to 3W of 800 nm light for 60 s. This led to a 75% reduction in uninfected MCF 10A cells, but only a 60% reduction when this cell line was infected. Uninfected MDA MB 231 cells subjected to 250 ug/ml of CSNPs and 800 nm (3W for 60 s had a 40% reduction in viability, and the infected cells had a 70% reduction. Differences in cell response to PTT whether the cells were infected or not indicates that infected TNBC cells may be preferentially more sensitive to CSNP-induced PTT. The CSNPs could be imaged within the cells, setting the stage for using this CSNPs for detection of breast cancer and precision photothermal ablation.

Symposium Organizers

Weibo Cai, University of Wisconsin--Madison
Bella Manshian, KU Leuven
Dalong Ni, Shanghai Jiao Tong University.
Ruirui Qiao, The University of Queensland

Symposium Support

Bronze
EXODUS BIO
JINAN NANOMEDICINE (HONG KONG) CO., LIMITED
Journal of Nanobiotechnology
KeAi-Bioactive Materials
POP Biotechnologies
Portrai Inc.
Promega Corporation
RAYSOLUTION Healthcare Co., Ltd
Shandong Madic Technology Co., Ltd.
United Well Technologies (China) Limited

Session Chairs

Ruirui Qiao
Hao Song

In this Session